查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1975117

核醫設備市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、最終用戶、安裝類型、模式及階段分類

Nuclear Medicine Equipment Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Installation Type, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計核醫設備市場規模將從2025年的45億美元成長到2035年的82億美元，複合年成長率約為6.2%。 2025年市場規模預計為1,200台，2035年將達到2,000台。目前，單光子發射電腦斷層掃描（SPECT）佔最大的市場佔有率，達45%，其次是正子斷層掃描（PET），佔35%，混合影像系統佔20%。 SPECT的領先地位得益於其成本效益以及在心臟病學和腫瘤學領域的廣泛應用。市場上的主要企業包括西門子醫療、通用電氣醫療和飛利浦醫療，它們在技術創新和市場擴張方面都發揮著重要作用。

競爭格局深受各公司策略舉措的影響，例如西門子醫療對人工智慧增強成像技術的投資以及通用電氣醫療拓展其PET示蹤劑產品組合。法規結構，特別是美國食品藥物管理局管理局（FDA）和歐洲藥品管理局（EMA）的指導方針，對強調合規性和創新性的市場運作有重大影響。未來預測顯示，市場將維持強勁成長勢頭，預計2035年，研發投資的年增率將進一步提高。這一成長將由技術進步和慢性病患病率上升趨勢驅動。然而，高成本和嚴格的監管核准等挑戰依然存在。人工智慧和機器學習在診斷成像領域的應用有望透過提高診斷準確性和營運效率，開闢新的機會。

市場區隔
類型 SPECT影像系統、PET影像系統、平面閃爍顯像、混合成像等。
產品 伽馬攝影機、PET/CT掃描儀、SPECT/CT掃描儀、迴旋加速器、放射性藥物等。
服務 設備維護、諮詢、訓練、安裝、升級及其他服務。
科技 數位成像、類比成像、軟體解決方案、放射性藥物製造等。
成分 檢測器、準直器、資料擷取系統、處理單元、顯示器系統等。
應用領域 心臟病學、腫瘤學、神經病學、整形外科、內分泌學、腎臟病學、消化病學、呼吸內科及其他
最終用戶 醫院、診斷中心、研究機構、學術機構、專科診所及其他
安裝類型 新安裝、維修安裝及其他
模式 住院病人、門診病人及其他
步 臨床前階段、臨床階段、商業化階段、其他

核醫設備市場正經歷強勁成長，這主要得益於技術進步和對早期診斷日益成長的需求。單光子發射電腦斷層掃描（SPECT）憑藉其在心臟病學和腫瘤學領域的廣泛應用，引領市場。正子斷層掃描（PET）是第二大細分市場，由於其在檢測組織代謝變化方面的高精度，表現強勁。從區域來看，北美市場佔據領先地位，這得益於其完善的醫療基礎設施和先進技術的高普及率。歐洲位居第二，德國和英國由於醫療保健支出不斷成長和活性化的研究投入，做出了顯著貢獻。在亞太地區，中國和印度正憑藉著醫療設施的擴張和人們對核子醫學認知的提高，成為極具潛力的市場。戰略合作和政府促進核子醫學應用的政策進一步推動了市場成長。成像能力的提升和人工智慧在診斷中的應用，為相關人員創造了巨大的商機。

區域概覽

北美地區，尤其是美國，在核醫設備市場佔據主導地位。美國先進的醫療基礎設施和對研發的大量投入推動了市場成長。主要市場參與者的存在以及先進技術的高普及率進一步鞏固了該地區的主導地位。

其次，歐洲地區以德國、法國和英國為主導，這三個國家是主要貢獻者。這些國家擁有健全的醫療保健體系，並且高度重視技術創新。政府支持核子醫學在診斷和治療中應用的政策也扮演著至關重要的角色。

亞太地區市場正迅速擴張。中國和印度等國家對核醫設備的需求不斷增加。這一成長主要得益於醫療費用支出的增加以及人們對現代診斷技術的認知度提高。此外，政府為改善醫療基礎設施所做的努力也顯著促進了市場擴張。

拉丁美洲地區的核子醫學設備市場展現出巨大的成長潛力。巴西和墨西哥處於領先地位，不斷增加對醫療基礎設施的投資。慢性病盛行率的上升以及對早期診斷需求的成長是該地區市場成長的關鍵促進因素。

中東和非洲地區在核子醫學設備市場的佔有率正穩定成長。阿拉伯聯合大公國和南非是推動這一成長的主要力量。對醫療基礎設施的投資以及對先進診斷技術的日益重視是這些地區市場發展的關鍵因素。

主要趨勢和促進因素

核醫設備市場正經歷強勁成長，這主要得益於影像技術的進步和慢性病盛行率的上升。人工智慧（AI）在診斷影像中的應用是關鍵趨勢，它提高了診斷的準確性和效率。這項技術進步使得疾病的早期發現和個人化治療方案的發展成為可能，從而推動了市場擴張。

人口老化和癌症發病率上升是推動市場成長的關鍵因素，也增加了對先進診斷解決方案的需求。政府和醫療機構加大對核醫基礎設施的投資，進一步加速了市場成長。此外，非侵入性診斷方法的普及也促進了對核醫設備的需求。

隨著醫療基礎設施的不斷完善，新興市場蘊藏著豐富的機會。專注於提供具成本效益創新解決方案的公司有望佔據可觀的市場佔有率。此外，研究機構與設備製造商之間的合作能夠促進創新，確保市場持續發展並適應不斷變化的醫療需求。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • SPECT影像系統
    • PET影像系統
    • 平面閃爍顯像
    • 混合成像
    • 其他
  • 市場規模及預測：依產品分類
    • 伽馬攝影機
    • PET/CT掃描儀
    • SPECT/CT掃描儀
    • 迴旋加速器
    • 放射性藥物
    • 其他
  • 市場規模及預測：依服務分類
    • 設備維護和檢查
    • 諮詢
    • 訓練
    • 安裝
    • 升級
    • 其他
  • 市場規模及預測：依技術分類
    • 月球成像
    • 類比成像
    • 軟體解決方案
    • 放射性藥物生產
    • 其他
  • 市場規模及預測：依組件分類
    • 檢測器
    • 準直器
    • 數據採集系統
    • 處理單元
    • 顯示系統
    • 其他
  • 市場規模及預測：依應用領域分類
    • 心臟病學
    • 腫瘤學
    • 神經病學
    • 整形外科
    • 內分泌學
    • 腎臟病學
    • 胃腸病學
    • 肺科
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷中心
    • 研究機構
    • 學術機構
    • 專科診所
    • 其他
  • 市場規模及預測：依安裝類型分類
    • 新推出
    • 改裝安裝
    • 其他
  • 市場規模及預測：按模式
    • 住院病人
    • 門診治療
    • 其他
  • 市場規模及預測：依疾病階段分類
    • 臨床前
    • 臨床
    • 商業的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings Corporation
  • Hitachi Medical Systems
  • Shimadzu Corporation
  • Neusoft Medical Systems
  • Mediso Medical Imaging Systems
  • Digirad Corporation
  • SurgicEye
  • CMR Naviscan
  • DDD-Diagnostic
  • Sofie Biosciences
  • Medsight Technologies
  • Gamma Medica
  • Nordion
  • Biosensors International
  • Positron Corporation
  • Cardiarc

第9章 關於我們

簡介目錄
Product Code: GIS34459

The Nuclear Medicine Equipment Market is expected to expand from $4.5 billion in 2025 to $8.2 billion by 2035, with a CAGR of approximately 6.2%. In 2025, the Nuclear Medicine Equipment Market was estimated to have a volume of 1,200 units, with projections to reach 2,000 units by 2035. The Single Photon Emission Computed Tomography (SPECT) segment currently holds the largest market share at 45%, followed by Positron Emission Tomography (PET) at 35%, and hybrid imaging systems at 20%. The SPECT segment's dominance is driven by its cost-effectiveness and widespread application in cardiology and oncology. Key players in the market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, each playing a pivotal role in advancing technology and expanding market reach.

The competitive landscape is heavily influenced by these companies' strategic initiatives, such as Siemens Healthineers' investment in AI-enhanced imaging and GE Healthcare's focus on expanding its PET tracer portfolio. Regulatory frameworks, particularly the FDA and European Medicines Agency guidelines, significantly impact market operations, emphasizing compliance and innovation. Future projections indicate a robust growth trajectory, with a higher annual increase in R&D investment anticipated by 2035. This growth is driven by technological advancements and an increasing prevalence of chronic diseases. However, challenges such as high equipment costs and stringent regulatory approvals remain. The integration of AI and machine learning in imaging is expected to unlock new opportunities, enhancing diagnostic accuracy and operational efficiency.

Market Segmentation
TypeSPECT Imaging Systems, PET Imaging Systems, Planar Scintigraphy, Hybrid Imaging, Others
ProductGamma Cameras, PET/CT Scanners, SPECT/CT Scanners, Cyclotrons, Radiopharmaceuticals, Others
ServicesEquipment Maintenance, Consulting, Training, Installation, Upgradation, Others
TechnologyDigital Imaging, Analog Imaging, Software Solutions, Radiopharmaceutical Production, Others
ComponentDetectors, Collimators, Data Acquisition Systems, Processing Units, Display Systems, Others
ApplicationCardiology, Oncology, Neurology, Orthopedics, Endocrinology, Nephrology, Gastroenterology, Pulmonology, Others
End UserHospitals, Diagnostic Centers, Research Institutes, Academic Institutions, Specialty Clinics, Others
Installation TypeNew Installation, Retrofit Installation, Others
ModeInpatient, Outpatient, Others
StagePreclinical, Clinical, Commercial, Others

The nuclear medicine equipment market is witnessing robust growth, driven by technological advancements and increasing demand for early diagnosis. The SPECT (Single Photon Emission Computed Tomography) segment dominates due to its widespread application in cardiology and oncology. PET (Positron Emission Tomography) follows as the second-highest performing sub-segment, benefiting from its precision in detecting metabolic changes in tissues. Among regions, North America leads the market, supported by a well-established healthcare infrastructure and high adoption of advanced technologies. Europe ranks second, with significant contributions from Germany and the UK, driven by rising healthcare expenditure and research activities. In Asia-Pacific, China and India are emerging as lucrative markets due to expanding healthcare facilities and increasing awareness about nuclear medicine. The market's growth is further fueled by strategic collaborations and government initiatives promoting the adoption of nuclear medicine. Enhanced imaging capabilities and the integration of AI in diagnostics present lucrative opportunities for stakeholders.

Geographical Overview

The North American region dominates the nuclear medicine equipment market, primarily driven by the United States. The countrya™s advanced healthcare infrastructure and significant investment in research and development propel market growth. The presence of key market players and a high adoption rate of advanced technologies further enhance this region's leading position.

Europe follows closely, with Germany, France, and the United Kingdom being major contributors. These countries have a robust healthcare system and a strong focus on technological advancements. Government initiatives supporting nuclear medicine applications in diagnostics and treatment also play a crucial role.

In the Asia Pacific, the market is rapidly expanding. Countries like China and India are witnessing increased demand for nuclear medicine equipment. This growth is driven by rising healthcare expenditures and a growing awareness of modern diagnostic techniques. Additionally, government efforts to improve healthcare infrastructure contribute significantly to the market's expansion.

Latin America shows promising growth potential in the nuclear medicine equipment market. Brazil and Mexico are at the forefront, with increasing investments in healthcare infrastructure. The rising prevalence of chronic diseases and a growing demand for early diagnosis are key factors driving market growth in this region.

The Middle East and Africa region is gradually emerging in the nuclear medicine equipment market. The United Arab Emirates and South Africa are leading this growth. Investments in healthcare infrastructure and an increasing focus on advanced diagnostic techniques are significant contributors to the market's development in these regions.

Key Trends and Drivers

The Nuclear Medicine Equipment Market is experiencing robust growth, propelled by advancements in imaging technologies and increased prevalence of chronic diseases. Key trends include the integration of artificial intelligence in diagnostic imaging, enhancing accuracy and efficiency. This technological evolution is enabling early disease detection and personalized treatment plans, driving market expansion.

The growing geriatric population and rising cancer incidence are significant drivers, necessitating advanced diagnostic solutions. Governments and healthcare institutions are investing in nuclear medicine infrastructure, further fueling market growth. Additionally, the shift towards non-invasive diagnostic procedures is boosting demand for nuclear medicine equipment.

Opportunities are abundant in emerging markets where healthcare infrastructure is expanding. Companies focusing on cost-effective and innovative solutions are poised to capture significant market share. Furthermore, collaborations between research institutions and equipment manufacturers are fostering innovation, ensuring the market's continuous evolution and adaptation to emerging healthcare needs.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Mode
  • 2.10 Key Market Highlights by Stage

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 SPECT Imaging Systems
    • 4.1.2 PET Imaging Systems
    • 4.1.3 Planar Scintigraphy
    • 4.1.4 Hybrid Imaging
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Gamma Cameras
    • 4.2.2 PET/CT Scanners
    • 4.2.3 SPECT/CT Scanners
    • 4.2.4 Cyclotrons
    • 4.2.5 Radiopharmaceuticals
    • 4.2.6 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Equipment Maintenance
    • 4.3.2 Consulting
    • 4.3.3 Training
    • 4.3.4 Installation
    • 4.3.5 Upgradation
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Digital Imaging
    • 4.4.2 Analog Imaging
    • 4.4.3 Software Solutions
    • 4.4.4 Radiopharmaceutical Production
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Detectors
    • 4.5.2 Collimators
    • 4.5.3 Data Acquisition Systems
    • 4.5.4 Processing Units
    • 4.5.5 Display Systems
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Cardiology
    • 4.6.2 Oncology
    • 4.6.3 Neurology
    • 4.6.4 Orthopedics
    • 4.6.5 Endocrinology
    • 4.6.6 Nephrology
    • 4.6.7 Gastroenterology
    • 4.6.8 Pulmonology
    • 4.6.9 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes
    • 4.7.4 Academic Institutions
    • 4.7.5 Specialty Clinics
    • 4.7.6 Others
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 New Installation
    • 4.8.2 Retrofit Installation
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Inpatient
    • 4.9.2 Outpatient
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Stage (2020-2035)
    • 4.10.1 Preclinical
    • 4.10.2 Clinical
    • 4.10.3 Commercial
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Mode
      • 5.2.1.10 Stage
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Mode
      • 5.2.2.10 Stage
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Mode
      • 5.2.3.10 Stage
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Mode
      • 5.3.1.10 Stage
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Mode
      • 5.3.2.10 Stage
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Mode
      • 5.3.3.10 Stage
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Mode
      • 5.4.1.10 Stage
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Mode
      • 5.4.2.10 Stage
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Mode
      • 5.4.3.10 Stage
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Mode
      • 5.4.4.10 Stage
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Mode
      • 5.4.5.10 Stage
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Mode
      • 5.4.6.10 Stage
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Mode
      • 5.4.7.10 Stage
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Mode
      • 5.5.1.10 Stage
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Mode
      • 5.5.2.10 Stage
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Mode
      • 5.5.3.10 Stage
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Mode
      • 5.5.4.10 Stage
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Mode
      • 5.5.5.10 Stage
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Mode
      • 5.5.6.10 Stage
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Mode
      • 5.6.1.10 Stage
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Mode
      • 5.6.2.10 Stage
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Mode
      • 5.6.3.10 Stage
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Mode
      • 5.6.4.10 Stage
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Mode
      • 5.6.5.10 Stage

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 GE Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Siemens Healthineers
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Canon Medical Systems
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Fujifilm Holdings Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Hitachi Medical Systems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Shimadzu Corporation
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Neusoft Medical Systems
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Mediso Medical Imaging Systems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Digirad Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 SurgicEye
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 CMR Naviscan
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 DDD-Diagnostic
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Sofie Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Medsight Technologies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Gamma Medica
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Nordion
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biosensors International
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Positron Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Cardiarc
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us